Cargando…

OM-85 BV in pediatric recurrent respiratory tract infections: a cost-utility analysis

BACKGROUND: Despite the growing evidence on efficacy, little is known regarding the cost-utility of Vaxom/Imocur (OM-85 BV) supplementation to decrease the probability of recurrent respiratory tract infections in OM-85 BV to reduce the incidence of recurrent respiratory tract infections in children....

Descripción completa

Detalles Bibliográficos
Autores principales:	Buendía, Jefferson Antonio, Patiño, Diana Guerrero, Lindarte, Erika Fernanda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724379/ https://www.ncbi.nlm.nih.gov/pubmed/36474205 http://dx.doi.org/10.1186/s12890-022-02264-9

Ejemplares similares

Podotimod in pediatric recurrent respiratory tract infections: a cost-utility analysis
por: Buendía, Jefferson Antonio, et al.
Publicado: (2022)

Cost-utility of vitamin D supplementation to prevent acute respiratory infections in children
por: Buendía, Jefferson Antonio, et al.
Publicado: (2023)

Bacterial lysates (OM-85 BV): a cost-effective proposal in order to contrast antibiotic resistance
por: TROIANO, GIANMARCO, et al.
Publicado: (2021)

Costs of Respiratory Syncytial Virus Hospitalizations in Colombia
por: Buendía, Jefferson Antonio, et al.
Publicado: (2020)

Effect of OM-85 BV on reducing bronchiectasis exacerbation in Chinese patients: the iPROBE study
por: Gao, Jinming, et al.
Publicado: (2021)

Cost-utility of triple versus dual inhaler therapy in moderate to severe asthma
por: Buendía, Jefferson Antonio, et al.
Publicado: (2021)

OM-85 BV for primary prevention of recurrent airway infections: a pilot randomized, double-blind, placebo-controlled study
por: de Souza, Fátima Cleonice, et al.
Publicado: (2020)

Cost-utility of as-needed ICS-formoterol versus to maintenance ICS in mild to moderate persistent asthma
por: Buendía, Jefferson Antonio, et al.
Publicado: (2021)

TLR4 Gene Polymorphisms Interaction With Ascaris Infection in Severe RSV Bronchiolitis
por: Buendía, Jefferson Antonio, et al.
Publicado: (2022)

Expert consensus on the role of OM-85 in the management of recurrent respiratory infections: A Delphi study
por: Esposito, Susanna, et al.
Publicado: (2022)

Prevention of respiratory tract infections with bacterial lysate OM-85 bronchomunal in children and adults: a state of the art
por: De Benedetto, Fernando, et al.
Publicado: (2013)

Impact of OM-85 Given during Two Consecutive Years to Children with a History of Recurrent Respiratory Tract Infections: A Retrospective Study
por: Esposito, Susanna, et al.
Publicado: (2019)

Cost-effectiveness analysis of OM-85 vs placebo in the prevention of acute respiratory tract infections (ARTIs) in children that attend day-care centers
por: Berber, Arturo, et al.
Publicado: (2019)

Fractional exhaled nitric oxide and eosinophil count in induced sputum to guide the management of children with asthma: a cost-utility analysis
por: Buendía, Jefferson Antonio, et al.
Publicado: (2022)

Importance of respiratory syncytial virus as a predictor of hospital length of stay in bronchiolitis
por: Buendia, Jefferson Antonio, et al.
Publicado: (2022)

Cost-effectiveness of procalcitonin for detection of serious bacterial infections in children presenting with fever without source
por: Buendía, Jefferson Antonio, et al.
Publicado: (2022)

Clinical and Immunological Benefits of OM-85 Bacterial Lysate in Patients with Allergic Rhinitis, Asthma, and COPD and Recurrent Respiratory Infections
por: Koatz, Ana M., et al.
Publicado: (2016)

OM-85 is an immunomodulator of interferon-β production and inflammasome activity
por: Dang, A. T., et al.
Publicado: (2017)

A randomized, placebo-controlled, double-blinded, single-centre, phase IV trial to assess the efficacy and safety of OM-85 in children suffering from recurrent respiratory tract infections
por: Esposito, Susanna, et al.
Publicado: (2019)

Airway Administration of Bacterial Lysate OM-85 Protects Mice Against Respiratory Syncytial Virus Infection
por: Antunes, Krist Helen, et al.
Publicado: (2022)

Effects of the Bacterial Extract OM-85 on Phagocyte Functions and the Stress Response
por: Baladi, S., et al.
Publicado: (1994)

Microbiota profiles in pre-school children with respiratory infections: Modifications induced by the oral bacterial lysate OM-85
por: Esposito, Susanna, et al.
Publicado: (2022)

Can bacterial lysates be useful in prevention of viral respiratory infections in childhood? The results of experimental OM-85 studies
por: Ballarini, Stefania, et al.
Publicado: (2022)

Budget impact analysis of surfactant therapy for bronchiolitis in critically ill infants: the Colombian National Health System perspective
por: Buendía, Jefferson Antonio, et al.
Publicado: (2021)

Disability-adjusted life years for acute bronchiolitis in infants in Colombia
por: Buendía, Jefferson Antonio, et al.
Publicado: (2021)

Impact of the updating of clinical guidelines for RSV bronchiolitis on the use of diagnostic testing and medications in tertiary hospitals in Colombia
por: Buendía, Jefferson Antonio, et al.
Publicado: (2022)

Use of the Bacterial Lysate OM-85 in the Paediatric Population in Italy: A Retrospective Cohort Study
por: Cantarutti, Anna, et al.
Publicado: (2021)

The OM-85 bacterial lysate: a new tool against SARS-CoV-2?
por: Pivniouk, Vadim, et al.
Publicado: (2023)

Effect of Broncho-Vaxom (OM-85) on the frequency of chronic obstructive pulmonary disease (COPD) exacerbations
por: Choi, Joon Young, et al.
Publicado: (2023)

Protection against neonatal respiratory viral infection via maternal treatment during pregnancy with the benign immune training agent OM‐85
por: Lauzon‐Joset, Jean‐Francois, et al.
Publicado: (2021)

Evidence that a primary anti-viral stimulation of the immune response by OM-85 reduces susceptibility to a secondary respiratory bacterial infection in mice
por: Rossi, Giovanni A., et al.
Publicado: (2018)

Adjuvant treatment with the bacterial lysate (OM-85) improves management of atopic dermatitis: A randomized study
por: Bodemer, Christine, et al.
Publicado: (2017)

IRF7-Associated Immunophenotypes Have Dichotomous Responses to Virus/Allergen Coexposure and OM-85-Induced Reprogramming
por: de Jong, Emma, et al.
Publicado: (2021)

Selective Activation of Human Dendritic Cells by OM-85 through a NF-kB and MAPK Dependent Pathway
por: Parola, Carmen, et al.
Publicado: (2013)

The cost-utility of early use of high-flow nasal cannula in bronchiolitis
por: Buendía, Jefferson Antonio, et al.
Publicado: (2021)

Cost utility of fractional exhaled nitric oxide monitoring for the management of children asthma
por: Buendía, Jefferson Antonio, et al.
Publicado: (2021)

To investigate the prevention of OM-85 on bronchiectasis exacerbations (iPROBE) in Chinese patients: study protocol for a randomized controlled trial
por: Gao, Jinming, et al.
Publicado: (2014)

Health Tract, No. 85: The Sabbath Rest
Publicado: (1862)

Health Tract, No. 85: The Sabbath Rest
Publicado: (1865)

Identifying Organic Matter (OM) Types and Characterizing OM Pores in the Wufeng–Longmaxi Shales
por: Xie, Guoliang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3dthqaihr5ua78bv980ehgoc26